Your current location:  News
  • Obtaining Class III medical device registration with Brazil's ANVISA typically takes 12 to 18 months, although the timeline can vary depending on several factors such as the complexity of the device, completeness of the application, and any additional requirements like inspections.
  • No, Class III medical device registration with Brazil's ANVISA does not require annual renewal. However, it is important to note that medical device registrations in Brazil are valid for a period of 5 years from the date of approval.
  • Class III medical device registration with Brazil's ANVISA offers several key benefits, particularly for manufacturers and companies looking to enter or expand in the Brazilian healthcare market. The Class III category represents high-risk devices, so obtaining approval from ANVISA is a significant milestone that provides both market access and regulatory assurance.
  • Completeness of Documentation: If the submitted documentation is thorough and complete, it can speed up the review process. Missing or incomplete documents may lead to delays as ANVISA will request additional information.
  • Class III medical device registration with Brazil's ANVISA refers to the formal approval process by which medical devices classified as Class III are authorized for sale and use in Brazil. Class III devices are considered to be the highest risk category within Brazil's medical device classification system. These devices typically involve significant risks to patient safety and health, such as implantable devices, pacemakers, and other critical medical equipment.
  • To apply for Class III medical device registration with Brazil’s ANVISA (National Health Surveillance Agency), a structured and detailed process must be followed. Class III devices are high-risk products, such as implantable devices or critical life-support equipment, and thus the registration process involves stringent requirements and documentation.
  • The registration process for Class III medical devices with Brazil's ANVISA (National Health Surveillance Agency) is detailed and rigorous, as these devices are considered to have a high potential risk to the patient and require extensive evaluation. The process includes submission of technical documentation, potential inspections, and compliance with ANVISA’s regulations.
  • To apply for Class III medical device registration with Brazil's ANVISA (National Health Surveillance Agency), you must follow a structured process that involves preparing detailed documentation, submitting the application, and complying with specific regulations.